Neil Shahrestani ’11 was recently interviewed on CNBC to discuss stocks for biotech companies that are working on drugs to fight the Ebola virus. Shahrestani currently works at Pura Vida Investments, a healthcare-focused investment vehicle, and previously worked at Goldman Sachs in the healthcare investment banking division.
Watch the interview on the CNBC website.
